{{Refimprove|date=February 2013}}
{{chembox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 444299907
| ImageFile=Pranidipine structure.svg
| ImageSize=
| IUPACName=methyl (2''E'')-phenylprop-2-en-1-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
| OtherNames=2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid O<sup>5</sup>-methyl O<sup>3</sup>-[(''E'')-3-phenylprop-2-enyl] ester
|Section1={{Chembox Identifiers
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 9DES9QVH58
| CASNo_Ref = {{cascite|correct|??}}
| CASNo=99522-79-9
| PubChem=6436048
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1096842
| SMILES=CC1=C(C(C(=C(N1)C)C(=O)OCC=CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 4940726
| InChI = 1/C25H24N2O6/c1-16-21(24(28)32-3)23(19-12-7-13-20(15-19)27(30)31)22(17(2)26-16)25(29)33-14-8-11-18-9-5-4-6-10-18/h4-13,15,23,26H,14H2,1-3H3/b11-8+
| InChIKey = XTFPDGZNWTZCMF-DHZHZOJOBA
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C25H24N2O6/c1-16-21(24(28)32-3)23(19-12-7-13-20(15-19)27(30)31)22(17(2)26-16)25(29)33-14-8-11-18-9-5-4-6-10-18/h4-13,15,23,26H,14H2,1-3H3/b11-8+
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = XTFPDGZNWTZCMF-DHZHZOJOSA-N
| RTECS = 
| MeSHName = C048161
  }}
|Section2={{Chembox Properties
| Formula=C<sub>25</sub>H<sub>24</sub>N<sub>2</sub>O<sub>6</sub>
| MolarMass=448.46786
| Appearance=
| Density=
| MeltingPt=
| BoilingPt=
| Solubility=
  }}
|Section3={{Chembox Hazards
| MainHazards=
| FlashPt=
| AutoignitionPt =
  }}
}}
'''Pranidipine''' is a [[calcium channel blocker]]. It is a long acting calcium channel antagonist of the [[dihydropyridine]] group.<ref name=nps01>{{ cite journal |author1=Jin Yang |author2=Keisuke Fukuo |author3=Shigeto Morimoto |author4=Tadaaki Niinobu |author5=Toshimitsu Suhara |author6=Toshio Ogihara | title = Pranidipine Enhances the Action of Nitric Oxide Released From Endothelial Cells | journal = Hypertension | year = 2000 | volume = 35 | pages = 82â€“85 | url = http://hyper.ahajournals.org/content/35/1/82.full | doi=10.1161/01.hyp.35.1.82}}</ref>

==References==

{{Reflist}}

{{Calcium channel blockers}}

[[Category:Calcium channel blockers]]
[[Category:Dihydropyridines]]
[[Category:Carboxylate esters]]
[[Category:Nitrobenzenes]]
[[Category:Methyl esters]]


{{Cardiovascular-drug-stub}}